“Fenoldopam as a Possible Medication for Non-Occlusive Mesenteric Ischemia (NOMI) and Contrast-Induced Nephropathy?” (2022) Bangladesh Journal of Infectious Diseases, 8(1), pp. 53–54. doi:10.3329/bjid.v8i1.53742.